EFFECT OF LUNASIN-ENRICHED SOY EXTRACT ON HISTONE DEACETYLASE EXPRESSION IN DISTAL COLON EPITHELIAL CELLS FROM AOM/DSS-INDUCED MICE
Objective: Lunasin peptide, with its chemopreventive and chemotherapeutic abilities, is known to affect carcinogenesis via epigenetic regulation involving histone acetylation. This study investigated lunasin, which can be found in soy, and its effects towards histone deacetylase (HDAC] expression in a mouse model of carcinogenesis.
Methods: Thirty Swiss Webster mice were grouped into normal, positive control, negative control, and experimental groups. Except for the normal group, mice underwent carcinogenesis induction through azoxymethane (AOM] and dextran sodium sulfate (DSS] injection. Experimental mice received lunasin-enriched soy extract at a dosage of 250 mg/kg BW (kilogram body weight), 300 mg/kg BW, and 350 mg/kg BW for 4 w. Distal colon samples were stained by using immunohistochemistry (IHC]. HDAC expression was measured by IHC optical density score.
Results: Average HDAC expression was 202.4% in the normal group, 239.3% in the negative control, 175.25% in the positive control, 202.03% at 250 mg/kg BW dose, 219.53% at 300 mg/kg, and 166.68% at 350 mg/kg BW. There was no significant difference between HDAC expression at 250 mg/kg BW and 300 mg/kg BW soy extract. However, at 350 mg/kg BW soy extract there were significant changes in HDAC expression.
Conclusion: lunasin in soy extract at a 350 mg/kg BW dose can decrease HDAC expression in a colorectal cancer carcinogenesis model.
2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet Tieulent J, Jemal A. Global cancer statistics, 2012: global cancer statistics 2012. CA Cancer J Clin 2015;65:87–108.
3. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut 2017;66:683–91.
4. Marshall JL. Managing potentially resectable metastatic colon cancer. Gastrointest Cancer Res GCR 2008;2(4 Suppl):S23-S26.
5. Bhutia SK, Maiti TK. Targeting tumors with peptides from natural sources. Trends Biotechnol 2008;26:210–7.
6. Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology 2010;138:2101–14. e5.
7. Yan L, Spitznagel EL, Bosland MC. Soy consumption and colorectal cancer risk in humans: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2010;19:148–58.
8. Jeong HJ, Jeong JB, Kim DS, de Lumen BO. Inhibition of core histone acetylation by the cancer preventive peptide lunasin. J Agric Food Chem 2007;55:632–7.
9. Gonzalez de Mejia E, Vasconez M, de Lumen BO, Nelson R. Lunasin concentration in different soybean genotypes, commercial soy protein, and isoflavone products. J Agric Food Chem 2004;52:5882–7.
10. Devapatla B, Shidal C, Yaddanapudi K, Davis KR. Validation of syngeneic mouse models of melanoma and non-small cell lung cancer for investigating the anticancer effects of the soy-derived peptide Lunasin. F1000 Res 2016;5:2432.
11. Dia VP, Mejia EG de. Lunasin promotes apoptosis in human colon cancer cells by mitochondrial pathway activation and induction of nuclear clusterin expression. Cancer Lett 2010;295:44–53.
12. Galvez AF, Chen N, Macasieb J, de Lumen BO. Chemopreventive property of a soybean peptide [lunasin] that binds to deacetylated histones and inhibits acetylation. Cancer Res 2001;61:7473–8.
13. Hernandez Ledesma B, Hsieh CC, de Lumen BO. Lunasin, a novel seed peptide for cancer prevention. Peptides 2009;30:426–30.
14. Jeong JB, Jeong HJ, Park JH, Lee SH, Lee JR, Lee HK, et al. Cancer-preventive peptide lunasin from solanum nigrum l. inhibits acetylation of core histones H3 and H4 and phosphorylation of retinoblastoma protein [Rb]. J Agric Food Chem 2007;55:10707–13.
15. Amalia AW, Kusmardi, Elya B, Arsianti A. Inhibition of carcinogenesis by seed and soybean meal extract in colon of mice: apoptosis and dysplasia. Asian J Pharm Clin Res 2017;10:123–8.
16. Seyed Jafari SM, Hunger RE. IHC optical density score: a new practical method for quantitative immunohistochemistry image analysis. Appl Immunohistochem Mol Morphol 2017;25:e12–3.
17. Mariadason JM. HDACs and HDAC inhibitors in colon cancer. Epigenetics 2008;3:28–37.
18. Takahashi M, Wakabayashi K. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 2004;95:475–80.
19. Guo Y, Liu Y, Zhang C, Su ZY, Li W, Huang MT, et al. The epigenetic effects of aspirin: the modification of histone H3 lysine 27 acetylation in the prevention of colon carcinogenesis in azoxymethane-and dextran sulfate sodium-treated CF-1 mice. Carcinogenesis 2016;37:616–24.
20. Sonnemann J, Hüls I, Sigler M, Palani CD, Hong LTT, Völker U, et al. Histone deacetylase inhibitors and aspirin interact synergistically to induce cell death in ovarian cancer cells. Oncol Rep 2008;20:219–24.
21. Susanto GWA, Nugrahaeni N. Pengenalan dan karakteristik varietas unggul kedelai. Balai Penelitian Tanaman Aneka Kacang dan Umbi; 2017.
22. Hernandez Ledesma BC, Hsieh CO, de Lumen B. Chemopreventive properties of peptide lunasin: a review. Protein Pept Lett 2013;20:424–32.
23. Paucar Menacho LM, Amaya Farfan J, Berhow MA, Mandarino JMG, Mejia EG de, Chang YK. A high-protein soybean cultivar contains lower isoflavones and saponins but higher minerals and bioactive peptides than a low-protein cultivar. Food Chem 2010;120:15–21.
24. Gargalionis AN, Piperi C, Adamopoulos C, Papavassiliou AG. Histone modifications as a pathogenic mechanism of colorectal tumorigenesis. Int J Biochem Cell Biol 2012;44:1276–89.
25. Hernandez Ledesma B, de Lumen BO. Lunasin: a novel cancer preventive seed peptide. Perspect Med Chem 2008;2:75–80.
This work is licensed under a Creative Commons Attribution 4.0 International License.